ZNTL
Zentalis Pharmaceuticals, Inc. · Healthcare
Director Cam Gallagher sold $449K of Zentalis Pharmaceuticals, Inc.
Sold$449,387
$44.94Price
10,000Shares
−3%Stake
What ZNTL did after the filing
- The stock from Tue, Mar 8 close, $44.00
- −44.2%
- S&P 500, same days
- +7.2%
Measured over 30 trading days, to the Apr 20 close.
Traded Mon, Mar 7. Filed Tue, Mar 8, 2:43 PM ET, during the session. Returns use the Mar 8 close and the Apr 20 close. Not investment advice.